On 13th March, a group of leading medical device development companies from Cambridge was asked by the UK Government to assist in the rapid development and manufacture of ventilators to meet increased hospital requirements, caused by COVID-19.
Cambridge Consultants, PA Consulting, Sagentia, Team Consulting and TTP plc took up the challenge and MetLase provided industrial support. These companies represent the renowned Cambridge Cluster, Europe’s largest technology hub, with more than 1,500 companies employing tens of thousands.
The UK’s engineering community has responded to the government’s call for help. These five specialist medical device development organisations are applying a range of disciplines, including electronics, software development, mechanical engineering, human factors, design, thermodynamics and regulatory knowledge.
This initiative unites competing businesses during an unprecedented public health emergency. With hundreds of experts working night and day, and in close cooperation, the Cambridge community has come together to address this challenge.
The companies are all working to a specification published by the government, established in response to the clinical interventions understood to be effective in the treatment of COVID-19. While working on separate, parallel designs, the group is collaborating closely to support each other.
High volume supply and extremely rapid manufacture are the key objectives, while remaining subject to testing and approval through the Medicines and Healthcare products Regulatory Agency - MHRA. This is a huge technical challenge. In broad terms the companies are taking a development process that would normally take 5-6 years and attempting to deliver within 5-6 weeks, and against the background of distributed teams observing government separation guidelines.
Media enquiries can be directed to Wayne Bontoft at the Cabinet Office press office:
T: 0207 2766326
M: 07858 923590
Signed by Cambridge Consultants (part of Altran), MetLase (a joint venture owned by Unipart and Rolls Royce), PA Consulting, Sagentia (a division of Science Group plc), Team Consulting (an employee owned trust), and TTP plc (an employee owned company).
About Cambridge Consultants
Cambridge Consultants develops breakthrough products, services and intellectual property, and provides business consultancy in technology-critical issues for clients worldwide. For more than 60 years, the company has been helping its clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. With a team of more than 800 team members, including engineers, scientists, mathematicians and designers, in offices in Cambridge (UK), Boston (USA), Tokyo (Japan) and Singapore, Cambridge Consultants offers solutions across a diverse range of industries including medical technology, industrial and consumer products, digital health, energy and wireless communications.
Visit us: www.cambridgeconsultants.com
About Capgemini Invent
As the digital innovation, design and transformation brand of the Capgemini Group, Capgemini Invent enables CxOs to envision and shape the future of their businesses. Located in nearly 40 studios and more than 60 offices around the world, it comprises a 10,000+ strong team of strategists, data scientists, product and experience designers, brand experts and technologists who develop new digital services, products, experiences and business models for sustainable growth.
Capgemini Invent is an integral part of Capgemini, a global leader in partnering with companies to transform and manage their business by harnessing the power of technology. The Group is guided everyday by its purpose of unleashing human energy through technology for an inclusive and sustainable future. It is a responsible and diverse organization of over 325,000 team members in more than 50 countries. With its strong 55-year heritage and deep industry expertise, Capgemini is trusted by its clients to address the entire breadth of their business needs, from strategy and design to operations, fueled by the fast evolving and innovative world of cloud, data, AI, connectivity, software, digital engineering and platforms. The Group reported in 2021 global revenues of €18 billion.
Get The Future You Want
Visit us at www.capgemini.com/invent
- medical technology